Human leukocyte antigen (HLA) typing for transplant market is segmented into diagnostic applications and research application.

Human leukocyte antigen (HLA) typing for transplant market is segmented into diagnostic applications and research application.

Human Leukocyte Antigen (HLA) Typing for Transplant Market – Industry Trends and Forecast to 2029

Global Human Leukocyte Antigen (HLA) Typing for Transplant Market, By Products and Services (Reagents and Consumables, Instruments, Software and Services), Technology (Molecular Assay Technologies, Non- Molecular Assay Technologies), Transplant Type (Solid Organ Transplant, Hematopoietic Stem Cell Transplant), Application (Diagnostic Applications, Research Application), End User (Independent Reference Laboratories, Hospitals and Transplant Centers, Research Laboratories and Academic Institutes) – Industry Trends and Forecast to 2029

Global Human Leukocyte Antigen (HLA) Typing for Transplant Market Analysis and Size

·      Global Human Leukocyte Antigen (HLA) Typing for Transplant Market was valued at USD 778.19 million in 2021 and is expected to reach USD 1,483.61 million by 2029, registering a CAGR of 8.4% during the forecast period of 2022-2029. The "molecular assays" accounts for the largest technology segment in the human leukocyte antigen (HLA) typing for transplant market within the forecasted period owing to the benefits offered by molecular assays such as high procedural efficacy, low turnaround time, the study of multiple samples and real-time sample analysis. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Human Leukocyte Antigen (HLA) Typing for Transplant Market Definition

·      Human leukocyte antigen (HLA) typing determines if patients and donors are compatible for cord blood or bone marrow transplants. Human leukocyte antigens (HLA) are proteins found in our bodies. The human immune system uses these markers to determine which cells belong in your body and which cells are foreign.

Global Human leukocyte antigen (HLA) typing for transplant Market Scope

·      The human leukocyte antigen (HLA) typing for transplant market is segmented on the basis of products and services, technology, transplant type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Products and Services

·      Reagents and Consumables

·      Instruments

·      Software and Services

·      On the basis of products and services, the human leukocyte antigen (HLA) typing for transplant market is segmented into reagents and consumables, instruments and software and services.

Technology

·      Molecular Assay Technologies

·      Non- Molecular Assay Technologies

·      On the basis of technology, the human leukocyte antigen (HLA) typing for transplant market is segmented into molecular assay technologies and non- molecular assay technologies. Molecular assay technologies are sub-segmented into PCR-based molecular assays and sequencing-based molecular assays. PCR-based molecular assays are further sub-segmented into Real-time PCR, sequence-specific primer-PCR, sequence-specific oligonucleotide-PCR and other PCR-based molecular assays. The sequencing-based molecular assays are further sub-segmented into sanger sequencing, next-generation sequencing and other sequencing-based molecular assays. The molecular assay technologies accounts for the largest share of the market because of benefits offered by molecular assays such as high procedural efficacy, low turnaround time, the study of multiple samples and real-time sample analysis.

Transplant Type

·      Solid Organ Transplant

·      Hematopoietic Stem Cell Transplant

·      On the basis of transplant type, the human leukocyte antigen (HLA) typing for transplant market is segmented into solid organ transplant and hematopoietic stem cell transplant.

Application

·      Diagnostic Applications

·      Research Application

·      On the basis of application, the human leukocyte antigen (HLA) typing for transplant market is segmented into diagnostic applications and research application.

End User

·      Independent Reference Laboratories

·      Hospitals and Transplant Centres

·      Research Laboratories and Academic Institutes

·      On the basis of end user, the human leukocyte antigen (HLA) typing for transplant market is bifurcated into independent reference laboratories, hospitals and transplant centers, research laboratories and academic institutes.

Get the sample copy of Report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hla-typing-transplant-market

Human leukocyte antigen (HLA) typing for transplant Market Regional Analysis/Insights

·      The countries covered in the human leukocyte antigen (HLA) typing for transplant market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Competitive Landscape and Human Leukocyte Antigen (HLA) Typing For Transplant Market Share Analysis

·      The human leukocyte antigen (HLA) typing for transplant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to human leukocyte antigen (HLA) typing for transplant market.

Some of the major players operating in the human leukocyte antigen (HLA) typing for transplant market are 

·      Thermo Fisher Scientific (U.S)

·      QIAGEN (Netherlands)

·      Illumina (US)

·      CareDx, (US)

·      Immucor, (U.S)

·      Bio-Rad Laboratories, Inc. (U.S)

·      F. Hoffman-La Roche Ltd. (Switzerland)

·      Hologic, Inc. (U.S)

·      Luminex Corporation (U.S)

·      Biofortuna (UK)

·      Bruker (US)

·      Abbott (US)

·      Takara Bio Inc.,(Japan)

·      Omixon Inc., (Hungary)

·      Siemens (Germany)

·      EKF Diagnostics (UK)

·      BD (US), Fujirebio, (Japan)       

·      TBG Diagnostics Limited (Australia)

Full Access of Report @ https://www.databridgemarketresearch.com/reports/global-hla-typing-transplant-market

MAJOR TOC OF THE REPORT

·      INTRODUCTION

·      MARKET SEGMENTATION

·      EXECUTIVE SUMMARY

·      PREMIUM INSIGHTS

·      MARKET OVERVIEW

·      QUESTIONNAIRE

Get TOC Details

https://www.databridgemarketresearch.com/toc/?dbmr=global-hla-typing-transplant-market

Browse Trending Reports@

·      Asia-Pacific excipients market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2021 to 2028 and is expected to reach USD 1,725.27 million by 2028 from USD 1,024.70 million in 2020. Increasing demand for alternative routes of delivery/dosage forms and increasing need for pharmaceutical products across varied therapeutic areas are the major drivers which propelled the demand of the market in the forecast period.

https://www.databridgemarketresearch.com/reports/asia-pacific-excipients-market

·      The excipients market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.8% in the forecast period of 2021 to 2028 and is expected to reach USD 2,379.08 million by 2028. Increasing demand for alternative routes of delivery/dosage forms and increasing need for pharmaceutical excipients across varied therapeutic areas are the major drivers which propelled the demand of the excipients market in the forecast period.

https://www.databridgemarketresearch.com/reports/europe-excipients-market

·      The excipients market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.9% in the forecast period of 2021 to 2028 and is expected to reach USD 6,296.82 million by 2028. Increasing demand for alternative routes of delivery/dosage forms and increasing need for pharmaceutical excipients across varied therapeutic areas are the major drivers which propelled the demand of the excipients market in the forecast period.

https://www.databridgemarketresearch.com/reports/north-america-excipients-market

About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818  
Email: Sopan.gedam@databridgemarketresearch.com